AbbVie Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . AbbVie Inc
ABBV Stock  USD 214.04  0.31  0.14%   
AbbVie's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing AbbVie's valuation are provided below:
Gross Profit
42.6 B
Profit Margin
0.04
Market Capitalization
378.8 B
Enterprise Value Revenue
7.4091
Revenue
59.6 B
There are over one hundred nineteen available fundamental signals for AbbVie Inc, which can be analyzed over time and compared to other ratios. All traders should should validate AbbVie's prevailing fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable.

AbbVie Total Revenue

35.6 Billion

Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 10.1 B, Interest Expense of 3.4 B or Selling General Administrative of 7.5 B, as well as many indicators such as Price To Sales Ratio of 3.46, Dividend Yield of 0.0288 or PTB Ratio of 89.34. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Build AI portfolio with AbbVie Stock
Check out the analysis of AbbVie Correlation against competitors.

AbbVie Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding1.8 B2 B1.7 B
Slightly volatile
Total Assets85.7 B155.4 B82.9 B
Slightly volatile
Other Current Liabilities35 B33.4 B14.9 B
Slightly volatile
Total Current Liabilities46.8 B44.6 B21.5 B
Slightly volatile
Other Liabilities38.3 B36.5 B18.8 B
Slightly volatile
Property Plant And Equipment Net3.7 B5.9 B3.6 B
Slightly volatile
Accounts Payable1.9 B3.4 B1.8 B
Slightly volatile
Cash10.2 B6.4 B9.2 B
Pretty Stable
Non Current Assets Total132.3 B126 B64.9 B
Slightly volatile
Other Assets5.8 B5.6 B2.7 B
Slightly volatile
Cash And Short Term Investments10.7 B6.4 B9.6 B
Pretty Stable
Net Receivables7.2 B12.6 B6.9 B
Slightly volatile
Good Will42.2 B40.2 B20.8 B
Slightly volatile
Liabilities And Stockholders Equity85.7 B155.4 B82.9 B
Slightly volatile
Non Current Liabilities Total58.7 B107 B56.8 B
Slightly volatile
Inventory5 B4.8 B2.4 B
Slightly volatile
Other Current Assets3.6 B5.7 B3.5 B
Slightly volatile
Total Liabilities78.8 B151.6 B76.8 B
Slightly volatile
Property Plant And Equipment Gross14.8 B14.1 B6.2 B
Slightly volatile
Total Current Assets23.8 B29.4 B22.2 B
Slightly volatile
Intangible Assets72.5 B69.1 B36 B
Slightly volatile
Property Plant Equipment3.4 B5.7 B3.5 B
Slightly volatile
Short and Long Term Debt Total48.4 B78 B43.6 B
Slightly volatile
Long Term Debt43 B69.4 B38.8 B
Slightly volatile
Short Term Debt5 B7.8 B4.5 B
Slightly volatile
Common Stock15.4 M16.2 M1.6 B
Slightly volatile
Common Stock Total Equity15.4 M16.2 M669.5 M
Slightly volatile
Long Term Debt Total50.1 B68 B42.3 B
Slightly volatile
Capital Surpluse15.8 B22.1 B13.5 B
Slightly volatile
Long Term Investments475.7 M251.1 M483.3 M
Very volatile
Non Current Liabilities Other20.6 B31.8 B16.1 B
Slightly volatile
Short and Long Term Debt6.1 B7.8 B5.4 B
Slightly volatile
Net Invested Capital74.9 B81 B58.7 B
Slightly volatile
Capital Stock14.4 M16.2 M17.7 M
Slightly volatile

AbbVie Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization10.1 B9.6 B4.3 B
Slightly volatile
Selling General Administrative7.5 B12.8 B7.4 B
Slightly volatile
Total Revenue35.6 B64.8 B35.4 B
Slightly volatile
Gross Profit25.5 B45.3 B25.3 B
Slightly volatile
Other Operating Expenses57 B54.3 B27.9 B
Slightly volatile
Operating Income9.8 B10.5 B9.3 B
Slightly volatile
EBIT8.4 B7.5 B7.8 B
Slightly volatile
Research Development15.4 B14.7 B6.9 B
Slightly volatile
EBITDA12.1 B17.1 B11.7 B
Slightly volatile
Cost Of Revenue10.1 B19.4 B10.1 B
Slightly volatile
Total Operating Expenses36.6 B34.8 B17.1 B
Slightly volatile
Income Before Tax7.1 B4.3 B6.5 B
Pretty Stable
Net Income6.2 B4.9 B5.7 B
Slightly volatile
Net Income Applicable To Common Shares14.3 B13.6 B7.5 B
Slightly volatile
Selling And Marketing Expenses1.4 B2.4 B1.3 B
Slightly volatile
Net Income From Continuing Ops6.7 B4.9 B5.7 B
Slightly volatile
Non Recurring553.6 M801.5 M517.4 M
Slightly volatile
Interest Income782.5 M745.2 M535 M
Slightly volatile
Reconciled Depreciation6.3 B9.6 B4.3 B
Slightly volatile

AbbVie Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation1.1 B1 B513.7 M
Slightly volatile
Free Cash Flow12.5 B20.5 B12.4 B
Slightly volatile
Begin Period Cash Flow9.2 B14.7 B9.3 B
Slightly volatile
Depreciation10.1 B9.6 B4.3 B
Slightly volatile
Capital Expenditures640.3 M1.1 B625 M
Slightly volatile
Total Cash From Operating Activities13.1 B21.6 B13 B
Slightly volatile
Net Income6.2 B4.9 B5.7 B
Slightly volatile
End Period Cash Flow9.6 B6.4 B9.2 B
Pretty Stable
Dividends Paid7 B12.7 B6.1 B
Slightly volatile
Change To Netincome3.4 B3 B2.6 B
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.465.024.3511
Slightly volatile
Dividend Yield0.02880.03160.0343
Slightly volatile
Days Sales Outstanding79.6281.3673.3371
Pretty Stable
Free Cash Flow Yield0.08770.06520.0793
Pretty Stable
Operating Cash Flow Per Share5.729.577.45
Slightly volatile
Stock Based Compensation To Revenue0.010.01460.0126
Slightly volatile
Capex To Depreciation0.130.11610.302
Slightly volatile
EV To Sales4.126.025.1368
Slightly volatile
Free Cash Flow Per Share5.449.077.0886
Slightly volatile
ROIC0.170.10.1481
Slightly volatile
Inventory Turnover3.553.644.3392
Pretty Stable
Net Income Per Share2.742.183.3697
Pretty Stable
Days Of Inventory On Hand93.3410486.4665
Very volatile
Payables Turnover6.696.66.1473
Slightly volatile
Research And Ddevelopement To Revenue0.140.20.1797
Very volatile
Capex To Revenue0.02190.01990.0195
Slightly volatile
Cash Per Share4.832.835.7824
Pretty Stable
POCF Ratio10.3115.0412.9539
Very volatile
Interest Coverage3.553.7415.9318
Slightly volatile
Payout Ratio2.442.321.2135
Slightly volatile
Capex To Operating Cash Flow0.06750.05960.06
Slightly volatile
PFCF Ratio15.3120.2714.4559
Very volatile
Days Payables Outstanding55.5657.2367.9114
Very volatile
Income Quality4.153.952.4343
Slightly volatile
EV To Operating Cash Flow12.2618.0315.3038
Very volatile
PE Ratio69.4466.1333.7383
Slightly volatile
Return On Tangible Assets0.240.120.2173
Slightly volatile
EV To Free Cash Flow13.2219.0116.4704
Very volatile
Earnings Yield0.01490.01570.043
Slightly volatile
Intangibles To Total Assets0.440.630.5501
Slightly volatile
Current Ratio0.720.761.4062
Slightly volatile
Receivables Turnover4.14.645.0276
Pretty Stable
Graham Number14.939.118.2827
Pretty Stable
Capex Per Share0.280.50.3614
Slightly volatile
Revenue Per Share15.5528.6620.3317
Slightly volatile
Interest Debt Per Share23.4935.9427.1258
Slightly volatile
Debt To Assets0.620.580.5661
Pretty Stable
Enterprise Value Over EBITDA13.122.7416.563
Slightly volatile
Short Term Coverage Ratios3.023.1850.1358
Slightly volatile
Price Earnings Ratio69.4466.1333.7383
Slightly volatile
Operating Cycle173185160
Very volatile
Days Of Payables Outstanding55.5657.2367.9114
Very volatile
Dividend Payout Ratio2.442.321.2135
Slightly volatile
Price To Operating Cash Flows Ratio10.3115.0412.9539
Very volatile
Price To Free Cash Flows Ratio15.3120.2714.4559
Very volatile
Pretax Profit Margin0.07210.07590.2055
Slightly volatile
Ebt Per Ebit0.860.470.7549
Slightly volatile
Operating Profit Margin0.310.190.2786
Pretty Stable
Long Term Debt To Capitalization0.670.850.7806
Slightly volatile
Total Debt To Capitalization0.730.860.8872
Very volatile
Return On Capital Employed0.210.110.1827
Slightly volatile
Ebit Per Revenue0.310.190.2786
Pretty Stable
Quick Ratio0.60.641.2774
Slightly volatile
Dividend Paid And Capex Coverage Ratio1.711.84.7395
Slightly volatile
Net Income Per E B T0.721.040.8953
Slightly volatile
Cash Ratio0.160.14260.5603
Pretty Stable
Cash Conversion Cycle96.5711289.7316
Pretty Stable
Operating Cash Flow Sales Ratio0.280.30.3478
Pretty Stable
Days Of Inventory Outstanding93.3410486.4665
Very volatile
Days Of Sales Outstanding79.6281.3673.3371
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.750.850.924
Pretty Stable
Cash Flow Coverage Ratios0.330.320.3115
Pretty Stable
Fixed Asset Turnover7.679.889.4984
Slightly volatile
Capital Expenditure Coverage Ratio15.5917.3819.6339
Slightly volatile
Price Cash Flow Ratio10.3115.0412.9539
Very volatile
Enterprise Value Multiple13.122.7416.563
Slightly volatile
Debt Ratio0.620.580.5661
Pretty Stable
Cash Flow To Debt Ratio0.330.320.3115
Pretty Stable
Price Sales Ratio3.465.024.3511
Slightly volatile
Return On Assets0.03460.03640.0914
Slightly volatile
Asset Turnover0.570.480.5177
Slightly volatile
Net Profit Margin0.0830.08730.1777
Slightly volatile
Gross Profit Margin0.80.69990.7401
Pretty Stable

AbbVie Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap74 B118 B113.4 B
Slightly volatile
Enterprise Value50.9 B57.3 B62.5 B
Slightly volatile

AbbVie Fundamental Market Drivers

Forward Price Earnings15.2672
Cash And Short Term Investments5.6 B

AbbVie Upcoming Events

2nd of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
2nd of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue-3.3 B-3.5 B
Total Revenue64.8 B35.6 B
Cost Of Revenue19.4 B10.1 B
Stock Based Compensation To Revenue 0.01  0.01 
Research And Ddevelopement To Revenue 0.20  0.14 
Capex To Revenue 0.02  0.02 
Revenue Per Share 28.66  15.55 
Ebit Per Revenue 0.19  0.31 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY